Ademi LLP is investigating First Seacoast's recent $80.9 million transaction with Cambridge Financial for potential breaches of fiduciary duty by the board and unfair deal terms. The deal offers First Seacoast shareholders $17.25 per share in cash, but insiders stand to gain significant benefits through change of control arrangements. The agreement also restricts competing bids by imposing heavy penalties, raising concerns about whether the board is acting in all shareholders' best interests. The investigation aims to determine if the board fulfilled its legal duties during the transaction process.
Valeo SE disclosed the total number of voting rights and shares forming its share capital as of June 30, 2026. The company reported 245.6 million shares with a par value of €1 each, totaling 276.9 million theoretical voting rights and 272.8 million e...
Valeo has disclosed the total number of voting rights and shares composing its share capital as of June 30, 2026. The company reported a capital of €245,607,624 with 245,607,624 shares, theoretical voting rights totaling 276,898,916, and exercisable ...
A three-day online training on Pharmaceutical Regulatory Affairs in Asia is scheduled for October 20-22, 2026, aiming to help professionals understand diverse regulatory requirements across major Asian markets including China, India, Korea, and ASEAN...
The global workwear market, valued at $265.12 billion in 2025, is expected to grow to $344.71 billion by 2031 with a 4.5% CAGR. Growth is fueled by rising corporate employment worldwide, especially in Asia-Pacific, and increased focus on professional...
The global microalgae-based aquafeed market is projected to grow from $320 million in 2026 to $481 million by 2031, at an 8.5% CAGR. Key growth drivers include rapid cost reductions in closed photobioreactor farming, making algae competitive with fis...
